Published in Clin J Am Soc Nephrol on March 14, 2013
Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant (2014) 1.27
Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis. Clin J Am Soc Nephrol (2014) 0.99
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. Nephrol Dial Transplant (2015) 0.95
Neighborhood socioeconomic status, race, and mortality in young adult dialysis patients. J Am Soc Nephrol (2014) 0.87
Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation. BMC Nephrol (2014) 0.86
Identifying High-Risk Neighborhoods Using Electronic Medical Records: A Population-Based Approach for Targeting Diabetes Prevention and Treatment Interventions. PLoS One (2016) 0.86
Disparities in Temporal and Geographic Patterns of Declining Heart Disease Mortality by Race and Sex in the United States, 1973-2010. J Am Heart Assoc (2015) 0.84
Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis. Arthritis Rheumatol (2015) 0.83
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. Clin J Am Soc Nephrol (2016) 0.82
Characteristics and performance of minority-serving dialysis facilities. Health Serv Res (2013) 0.82
The association between geographic proximity to a dialysis facility and use of dialysis catheters. BMC Nephrol (2014) 0.82
Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics. Clin J Am Soc Nephrol (2015) 0.82
Pre-end-stage renal disease care not associated with dialysis facility neighborhood poverty in the United States. Am J Nephrol (2014) 0.81
Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care. Kidney Int (2015) 0.80
Relationship Between Age and Timely Placement of Vascular Access In Incident Patients on Hemodialysis. Nephrol Nurs J (2015) 0.77
Survival on dialysis among American Indians and Alaska Natives with diabetes in the United States, 1995-2010. Am J Public Health (2014) 0.77
Making the crooked way straight: interpreting geography and health care delivery in CKD. Clin J Am Soc Nephrol (2013) 0.75
Mapping end-stage renal disease (ESRD): spatial variations on small area level in northern France, and association with deprivation. PLoS One (2014) 0.75
Younger black patients have a higher risk of infection mortality that is mostly non-dialysis related: A national study of cause-specific mortality among U.S. maintenance dialysis patients. Hemodial Int (2016) 0.75
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc (2002) 15.61
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75
Understanding geographic variations in health care delivery. N Engl J Med (1999) 5.49
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Who you are and where you live: how race and geography affect the treatment of medicare beneficiaries. Health Aff (Millwood) (2004) 4.25
Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol (2005) 2.74
Socioeconomic status and the incidence of ESRD. Am J Kidney Dis (2008) 2.48
Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol (2009) 2.21
Rural-urban differences in usual source of care and ambulatory service use: analyses of national data using Urban Influence Codes. Med Care (2003) 2.21
Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol (2011) 2.13
Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA (2010) 2.12
Racial composition of residential areas associates with access to pre-ESRD nephrology care. J Am Soc Nephrol (2010) 2.07
Late referral of patients with chronic kidney disease: no time to waste. Mayo Clin Proc (2006) 2.04
Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant (1992) 2.03
Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis (1998) 1.85
Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant (1993) 1.85
Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med (2002) 1.82
A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol (2003) 1.78
Outcomes of early versus late nephrology referral in chronic kidney disease: a systematic review. Am J Med (2011) 1.70
Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant (2002) 1.59
Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant (2006) 1.54
Survival benefit of nephrologic care in patients with diabetes mellitus and chronic kidney disease. Arch Intern Med (2008) 1.41
Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis (1999) 1.40
Validation of reported predialysis nephrology care of older patients initiating dialysis. J Am Soc Nephrol (2012) 1.36
Hospital utilization among chronic dialysis patients. J Am Soc Nephrol (2000) 1.19
The deadly risk of late referral. Nephrol Dial Transplant (2004) 1.08
The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant (1998) 1.07
Fistula first: recent progress and ongoing challenges. Am J Kidney Dis (2011) 1.02
Geographic concentration of poverty and arteriovenous fistula use among ESRD patients. J Am Soc Nephrol (2010) 0.97
Predialysis nephrology care and costs in elderly patients initiating dialysis. Med Care (2011) 0.94
Unwanted variations in the rules of practice. JAMA (1991) 0.90
Predialysis nephrology care improves dialysis outcomes: now what? Or chapter two. Clin J Am Soc Nephrol (2006) 0.89
Lessons from geographic variations in predialysis nephrology care. J Am Soc Nephrol (2009) 0.84
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N Engl J Med (2006) 10.97
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science (2009) 10.78
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect (2005) 10.66
Regulation of cellular metabolism by protein lysine acetylation. Science (2010) 10.55
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell (2006) 6.15
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell (2007) 5.84
Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell (2010) 5.73
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol (2013) 5.21
A navigator for human genome epidemiology. Nat Genet (2008) 5.07
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet (2003) 4.79
A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. Am J Hum Genet (2007) 4.46
A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (2003) 4.37
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis (2010) 3.87
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial. Am J Kidney Dis (2011) 3.81
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol (2011) 3.52
Development and validation of a CGH microarray for clinical cytogenetic diagnosis. Genet Med (2005) 3.39
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer. J Clin Oncol (2010) 3.06
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83
Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet (2005) 2.80
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol (2006) 2.74
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci U S A (2004) 2.66
Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell (2012) 2.54
Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease. J Am Soc Nephrol (2006) 2.54
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49
Related causal frameworks for surrogate outcomes. Biometrics (2009) 2.46
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42
High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis (2003) 2.41
Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol (2006) 2.39
The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34
Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol (2006) 2.34
Epithelial polarity and tubulogenesis in vitro. Trends Cell Biol (2003) 2.31
Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol Cell (2011) 2.29
Building an academic-community partnered network for clinical services research: the Community Health Improvement Collaborative (CHIC). Ethn Dis (2006) 2.25
Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant (2005) 2.21
Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet (2005) 2.18
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int (2004) 2.16
Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol (2009) 2.15
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13
Cell-polarity dynamics controls the mechanism of lumen formation in epithelial morphogenesis. Curr Biol (2008) 2.13
Effect of frequent hemodialysis on residual kidney function. Kidney Int (2013) 2.10
Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens (2007) 2.09
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol (2005) 2.07
Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother (2013) 1.99
Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol (2005) 1.97
Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol (2013) 1.96
Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int (2002) 1.93
Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol (2010) 1.92
Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation (2002) 1.91
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol (2012) 1.90
Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89
Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth (2009) 1.88
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
Changes in dietary protein intake has no effect on serum cystatin C levels independent of the glomerular filtration rate. Kidney Int (2010) 1.88
Which hospitals have significantly better or worse than expected mortality rates for acute myocardial infarction patients? Improved risk adjustment with present-at-admission diagnoses. Circulation (2007) 1.87
High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int (2011) 1.86
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation (2012) 1.86
Performance of the Cockcroft-Gault and modification of diet in renal disease equations in estimating GFR in ill hospitalized patients. Am J Kidney Dis (2005) 1.83
Pyridorin in type 2 diabetic nephropathy. J Am Soc Nephrol (2011) 1.79
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med (2005) 1.76